Nupr1 deletion protects against glucose intolerance by increasing beta cell mass
Aims/hypothesis The stress-activated nuclear protein transcription regulator 1 (NUPR1) is induced in response to glucose and TNF-α, both of which are elevated in type 2 diabetes, and Nupr1 has been implicated in cell proliferation and apoptosis cascades. We used Nupr1 −/− mice to study the role of N...
Saved in:
Published in: | Diabetologia Vol. 56; no. 11; pp. 2477 - 2486 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01-11-2013
Springer Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims/hypothesis
The stress-activated nuclear protein transcription regulator 1 (NUPR1) is induced in response to glucose and TNF-α, both of which are elevated in type 2 diabetes, and
Nupr1
has been implicated in cell proliferation and apoptosis cascades. We used
Nupr1
−/−
mice to study the role of
Nupr1
in glucose homeostasis under normal conditions and following maintenance on a high-fat diet (HFD).
Methods
Glucose homeostasis in vivo was determined by measuring glucose tolerance, insulin sensitivity and insulin secretion. Islet number, morphology and beta cell area were assessed by immunofluorescence and morphometric analysis, and islet cell proliferation was quantified by analysis of BrdU incorporation. Islet gene expression was measured by gene arrays and quantitative RT-PCR, and gene promoter activities were monitored by measuring luciferase activity.
Results
Nupr1
−/−
mice had increased beta cell mass as a consequence of enhanced islet cell proliferation.
Nupr1
-dependent suppression of beta cell
Ccna2
and
Tcf19
promoter activities was identified as a mechanism through which
Nupr1
may regulate beta cell cycle progression.
Nupr1
−/−
mice maintained on a normal diet were mildly insulin resistant, but were normoglycaemic with normal glucose tolerance because of compensatory increases in basal and glucose-induced insulin secretion.
Nupr1
deletion was protective against HFD-induced obesity, insulin resistance and glucose intolerance.
Conclusions/interpretation
Inhibition of NUPR1 expression or activity has the potential to protect against the metabolic defects associated with obesity and type 2 diabetes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0012-186X 1432-0428 1432-0428 |
DOI: | 10.1007/s00125-013-3006-x |